BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7820574)

  • 1. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.
    Notermans NC; Wokke JH; Lokhorst HM; Franssen H; van der Graaf Y; Jennekens FG
    Brain; 1994 Dec; 117 ( Pt 6)():1385-93. PubMed ID: 7820574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
    Suarez GA; Kelly JJ
    Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathies associated with IgG and IgA monoclonal gammopathy.
    Nobile-Orazio E; Casellato C; Di Troia A
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):979-87. PubMed ID: 12407307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T
    Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.
    Simmons Z; Bromberg MB; Feldman EL; Blaivas M
    Muscle Nerve; 1993 Jan; 16(1):77-83. PubMed ID: 8380902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Dyck PJ; Low PA; Windebank AJ; Jaradeh SS; Gosselin S; Bourque P; Smith BE; Kratz KM; Karnes JL; Evans BA
    N Engl J Med; 1991 Nov; 325(21):1482-6. PubMed ID: 1658648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
    Mehndiratta MM; Sen K; Tatke M; Bajaj BK
    J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases.
    Magy L; Chassande B; Maisonobe T; Bouche P; Vallat JM; Léger JM
    Eur J Neurol; 2003 Nov; 10(6):677-85. PubMed ID: 14641513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyneuropathy associated with IgM monoclonal gammopathy: a review. Clinical, electrophysiological and pathological features.
    Leger JM; Vaunaize J
    Nouv Rev Fr Hematol (1978); 1990; 32(5):303-6. PubMed ID: 1965990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyneuropathy associated with IgA monoclonal gammopathy: a hypothesis of its pathogenesis.
    Nemni R; Mamoli A; Fazio R; Camerlingo M; Quattrini A; Lorenzetti I; Comola M; Galardi G; Canal N
    Acta Neuropathol; 1991; 81(4):371-6. PubMed ID: 1851362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D; Gorson KC; Ropper AH
    Acta Neurol Scand; 1998 Mar; 97(3):194-200. PubMed ID: 9531437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
    Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA; Wilson JR
    Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance.
    Kelly JJ
    Rev Neurol Dis; 2008; 5(1):14-22. PubMed ID: 18418318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
    Gorson KC
    J Clin Apher; 1999; 14(3):149-53. PubMed ID: 10540371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy.
    Notermans NC; Wokke JH; van den Berg LH; van der Graaf Y; Franssen H; Teunissen LL; Lokhorst HM
    Brain; 1996 Apr; 119 ( Pt 2)():421-7. PubMed ID: 8800937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy and neuropathy.
    Ramchandren S; Lewis RA
    Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyneuropathy associated with monoclonal gammapathy of undetermined significance].
    Mellibovsky Saidler L; Roquer González J; Corominas Torres JM; Tomás Cedó R; Pérez Vila E; Guelar Grimberg A; Coll Daroca J
    Med Clin (Barc); 1988 Jun; 91(3):88-92. PubMed ID: 2845203
    [No Abstract]   [Full Text] [Related]  

  • 20. Paraproteinemic neuropathies.
    Vital A
    Brain Pathol; 2001 Oct; 11(4):399-407. PubMed ID: 11556684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.